Skip to main content
Premium Trial:

Request an Annual Quote

Tataa Inks Distribution Deal for Yikon MALBAC Products

NEW YORK (GenomeWeb) — Tataa Biocenter has signed a deal to distribute and support Yikon Genomics' MALBAC single-cell whole-genome amplification products in Sweden, Norway, Germany, Austria, Slovakia , and the Czech Republic, the partners announced today. 

As part of the arrangement, Gothenburg, Sweden-based Tataa will also use the MALBAC technology in its next-generation sequencing training courses. Additional terms were not disclosed.

MALBAC, short for multiple annealing and looping-based amplification cycles, is designed to improve on the amount of genome that can be covered in whole genome amplification methods while also reducing amplification bias. It was developed by Harvard University's Sunney Xie. 

"We pioneered single cell transcriptomics over ten years ago and have the broadest product and services offerings in the field in Europe," Tataa CEO Mikael Kubista said in a statement. "Yikon's MALBAC technology … is a perfect complement to our current portfolio allowing us to offer also the best technology for single-cell genomics."

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.